Bardoxolone methyl improves survival and reduces clinical measures of kidney injury in tumor-bearing mice treated with cisplatin.

Saved in:
Bibliographic Details
Title: Bardoxolone methyl improves survival and reduces clinical measures of kidney injury in tumor-bearing mice treated with cisplatin.
Authors: Thompson LE; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Tuey SM; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Gonzalez PG; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Chesterman CS; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., McGinnis CD; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Lucia MS; Department of Pathology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Aleksunes LM; Environmental and Occupational Health Sciences Institute, Rutgers University, Piscataway, NJ, USA.; Department of Pharmacology and Toxicology, Ernest Mario School of Pharmacy, Rutgers University, Piscataway, NJ, USA., Edelstein CL; Division of Renal Diseases and Hypertension, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Joy MS; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.; Division of Renal Diseases and Hypertension, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.; University of Colorado Cancer Center, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Source: AAPS open [AAPS Open] 2025; Vol. 11. Date of Electronic Publication: 2025 Mar 03.
Publication Type: Journal Article
Journal Info: Publisher: SpringerOpen Country of Publication: England NLM ID: 101742151 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2364-9534 (Electronic) Linking ISSN: 23649534 NLM ISO Abbreviation: AAPS Open Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2364-9534
DOI:10.1186/s41120-025-00107-5